Cytokine modulation in experimental endotoxemia: Characterization of an ex vivo whole blood model

European Surgical Research

Volumn 32, Issue 2, 2000, Pages 65-73

  Wang, Jacob E ^a   Solberg, R ^b   Okkenhaug, Cecilie ^b   Jorgensen P F ^b   Krohn, C D ^b   Aasen, A O ^b  

^a UNIVERSITY OF OSLO   (Norway)

^b NONE

Author keywords

Cytokines; Lipopolysaccharides; Whole blood model

Indexed keywords

CARBON DIOXIDE; CD14 ANTIGEN; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCLONAL ANTIBODY; OXYGEN; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD; CARBON DIOXIDE TENSION; CELL COUNT; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; ENDOTOXEMIA; HUMAN; IN VITRO STUDY; LEUKOCYTE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0034059750     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008743     Document Type: Article

References (29)

1. Krohn CD, Reikerås O, Aasen AO: The cytokines IL-1β and IL-1 receptor antagonist, IL-2 and IL-2 soluble receptor-α, IL-6 and IL-6 soluble receptor, TNF-α and TNF soluble receptor I, and IL-10 in drained and systemic blood after major orthopaedic surgery. Eur J Surg 1999;165:101-109.
2. Cannon JG, Tompkins RG, Gelfand JA, Michie HR, Stanford GG, van der Meer JWM, Endres S, Honnemann G, Corsetti J, Chernow B, Wilmore DW, Wolff SM, Burke JF, Dinarello CA: Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis 1990;161:79-84.
3. Waage A, Brandtzæg P, Halstensen A, Kierulf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin-6, interleukin-1, and fatal outcome. J Exp Med 1989;169:333-338.
4. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-1433.
5. De Waal Malefyt R, Fidgor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE: Effects of IL-13 on phenotype, cytokine production, and cytokine function of human monocytes. Comparison with IL-4 and modulation by IFN-γ or IL-10. J Immunol 1993;151:6370-6381.
6. 2. Proc Natl Acad Sci USA 1989;86:3803-3807.
7. Essner R, Rhoades K, McBride WH, Morton DL, Exonomou JS: IL-4 downregulates IL-1 and TNF gene expression in human monocytes. J Immunol 1989;142:3857-3861.
8. te Velde AA, Huijbens RJF, Heije K, de Vries JE, Figdor CG: Interleukin-4 (IL-4) inhibits secretion of IL-1β, tumor necrosis factor α and IL-6 by human monocytes. Blood 1990;76: 1392-1397.
9. Viera P, De Waal Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, de Vries JE, Roncarlo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 1991; 88:1172-1176.
10. De Waal Malefyt R, Adams J, Bennett B, Figdor CG, de Bries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
11. Martin TR, Mathison JC, Tobias PS, Leturcq DJ, Moriarty AM, Maunder RJ, Ulevitch RJ: Lipopolysaccharide binding protein enhances the responsiveness of alveolar macrophages to bacterial lipopolysaccharide: Implications for cytokine production in normal and injured lungs. J Clin Invest 1992;90:2209-2219.
12. Mathison JC, Tobias PS, Wolfson E, Ulevitch RJ: Plasma lipopolysaccharide (LPS)-binding protein: A key component in macrophage recognition of Gram-negative LPS. J Immunol 1992;149:200-206.
13. Hart PH, Jones CA, Finlay-Jones JJ: Monocytes cultured in cytokine-defined environments differ from freshly isolated monocytes in their response to IL-4 and IL-10. J Leukoc Biol 1995;57:909-918.
14. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95: 99-105.
15. Solberg R. Scholz T, Videm V, Okkenhaug C, Aasen AO: Heparin coating reduces cell activation and mediator release in an in vitro venovenous bypass model for liver transplantation. Transplant 1998;11:252-258.
16. Ghezzi P, Dinarello CA, Bianchi M, Roandich ME, Repine JE, White CW: Hypoxia increases production of interleukin-1 and tumor necrosis factor by human mononuclear cells. Cytokine 1991;3:189-194.
17. Knowlers R, Keeping H, Graeber T, Nguyen K, Garner C, D'Amico R, Simms HH: Cytokine control of PMN phagocytosis: Regulatory effects of hypoxemia and hypoxemia-reoxygenation. Am J Physiol 1997;272:C1352-C1364.
18. Herbert JM, Corseaux D, Lale A, Bernat A: Hypoxia primes endotoxin-induced tissue factor expression in human monocytes and endothelial cells by a PAF-dependent mechanism. J Cell Physiol 1996;169:290-299.
19. Hyllner M, Arnestad JP, Bengtson JP, Rydberg L, Bengtsson A: Complement activation during storage of whole blood, red cells, plasma, and buffy coat. Transfusion 1997;37:264-268.
20. Muylle L, Joos M, Wouters E, De Bock R, Peetermans ME: Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: Relationship between TNF alpha and IL-6 levels and febrile transfusion reactions. Transfusion 1993;33:195-199.
21. Wright SD, Ramos RA, Hermanowski-Vosatka A, Rockwell P, Detmers PA: Activation of the adhesive capacity of CR3 on neutrophils by endotoxin: Dependence on lipopolysaccharide binding protein and CD14. J Exp Med 1991; 173:1281-1286.
22. Jenkins JK, Jalyak M, Arend WP: The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils. Lymphokine Cytokine Res 1994;13:47-54.
23. Cassatella MA: The production of cytokines by polymorphonuclear neutrophils. Immunol Today 1995;16:21-26.
24. Ingalls RR, Golenbock DT: CD11c/CD18: A transmembrane signaling receptor for lipopolysaccharide. J Exp Med 1995;181:1473-1479.
25. Flaherty SF, Golenbock DT, Milham FH, Ingalls RR: CD11/CD18 leukocyte integrins: New signaling receptors for bacterial endotoxin. J Surg Res 1997;73:85-89.
26. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G: Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: Priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 1995;181:537-546.
27. Mijatovic T, Kruys V, Caput D, Defrance P, Huez G: Interleukin-4 and -13 inhibit tumor necrosis factor-α mRNA transcriptional activation in lipopolysaccharide-induced mouse macrophages. J Biol Chem 1997;272:14394-14398.
28. Dokter WHA, Koopmans SB, Vellenga E: Effects of IL-10 and IL-4 on EPS-induced transcription factors (AP-1, NF-IL6 and NF-κB) which are involved in IL-6 regulation. Leukemia 1996;10:1308-1316.
29. Wang P, Wu P, Siegel MI, Egan RW, Billah MM: IL-10 inhibits transcription of cytokine genes in human peripheral blood mononuclear cells. J Immunol 1994;153:811-816.